Cardiovascular safety of tyrosine kinase inhibitors: Putting their "QT-phobia" in perspective
Many potentially valuable drugs, including protein kinase inhibitors (PKI), risk being dropped from further development, without exploration of their clinical benefits, if early studies show these drugs to inhibit hERG channel and therefore, to have a potential for prolonging ventricular repolarisat...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
International Association of Physical Chemists (IAPC),
2016-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |